Inotek Pharmaceuticals
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
91 Hartwell Ave, Lexington, Massachusett...Phone Number
(781) 457-1446Website
www.inotekcorp.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Inotek Pharmaceuticals
Inotek Pharmaceuticals is a privately held biotechnology company dedicated to the discovery and development of innovative drugs for serious eye diseases. The company has a robust pipeline of drug candidates targeting inflammation, ischemia-reperfusion injury, and oxidative stress, with a focus on conditions such as Glaucoma and Ocular Hypertension. Their lead product, trabodenoson (INO-8875), is designed to lower intraocular pressure through a novel mechanism of action and has shown promising results in clinical trials. Inotek aims to advance its clinical programs towards commercialization to benefit patients and healthcare providers managing ocular diseases.Explore more
Popular SearchesInotek PharmaceuticalsInotek Pharmaceuticals CorpSIC Code 28,283NAICS Code 32,325Show more
Inotek Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Inotek Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Inotek Pharmaceuticals recently announced quarterly report
Funding: Get notified immidiatlly once Inotek Pharmaceuticals has new funding data
Click to see if Inotek Pharmaceuticals had a recent Job posting/layoffs
Check if Inotek Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Inotek Pharmaceuticals launches new products
Congratulate Masked Content for being promoted to Masked Content at Inotek Pharmaceuticals
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Inotek Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Inotek Pharmaceuticals is spiking on competitors!
Recommended Actions
Find VP level buyers at Inotek Pharmaceuticals
Find 2 more new buyers
Compare Similar Companies to Inotek Pharmaceuticals
Compare insights from companies similar to Inotek Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Inotek Pharmaceuticals
<$5M
11-50
Private
-
-
WM
William McVicarExecutive Vice President & Scientific Chief & Officer
Company Profile Activity
Activity Insights
Inotek Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Inotek Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Inotek Pharmaceuticals.
Inotek Pharmaceuticals Tech Stack
A closer look at the technologies used by Inotek Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Inotek Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Inotek Pharmaceuticals is a privately held biotechnology company dedicated to the discovery and development of innovative drugs for serious eye diseases. The company has a robust pipeline of drug candidates targeting inflammation, ischemia-reperfusion injury, and oxidative stress, with a focus on conditions such as Glaucoma and Ocular Hypertension.... Read More
